Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Clinical & Experimental Metastasis|October 15, 2021
Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysisCiro Franzese, Luca Nicosia, Giuseppe Facondo, et al.The Prostate|December 19, 2023
Long term update on toxicity and survival of a phase II trial of linac-based stereotactic body radiation therapy for low-intermediate risk prostate cancerGiuseppe R D'Agostino, Marco Badalamenti, Sara Stefanini, et al.Journal of Clinical Medicine|March 17, 2025
Hybrid Therapy with SBRT Target-Tailored Tumor Resection for High-Grade Metastatic Epidural Spinal Cord Compression (MESCC): Illustrative CaseMario De Robertis, Lorenzo Lo Faro, Linda Bianchini, et al.Journal of Cancer Research and Clinical Oncology|September 18, 2020
Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicityMauro Loi, Tiziana Comito, Ciro Franzese, et al.Diseases (Basel, Switzerland)|July 26, 2024
STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung LesionsDavide Franceschini, Mauro Loi, Antonio Marco Marzo, et al.Journal of Geriatric Oncology|January 19, 2021
Charlson comorbidity index and G8 in older old adult(≥80 years) hepatocellular carcinoma patients treated with stereotactic body radiotherapyMauro Loi, Tiziana Comito, Ciro Franzese, et al.Current Oncology (Toronto, Ont.)|October 27, 2022
Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II TrialDavide Franceschini, Tiziana Comito, Anna Di Gallo, et al.The British Journal of Radiology|February 22, 2023
Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factorsDavide Franceschini, Maria Ausilia Teriaca, Luciana Di Cristina, et al.Current Oncology (Toronto, Ont.)|December 22, 2022
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric TrialRaffaella Lucchini, Ciro Franzese, Suela Vukcaj, et al.Current Oncology (Toronto, Ont.)|July 25, 2022
Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive RadiotherapyMaria Massaro, Davide Franceschini, Ruggero Spoto, et al.Pageof 2